Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Trial ID or NCT#
Status
Purpose
The purpose of this trial is to determine whether treatment with valsartan will have beneficial effect in early hypertrophic cardiomyopathy (HCM) by assessing many domains that reflect myocardial structure, function and biochemistry.
Official Title
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Euan Ashley, MD, PhD
650-498-4900
View on ClinicalTrials.gov